Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities

To end the global tuberculosis (TB) epidemic and eliminate TB, countries around the world committed to significantly expanding the scope of their efforts, including rapid uptake of new tools, interventions, and strategies, and envisioned a world free of TB. Between 2010 and 2020, Ethiopia experienced a 5% average annual decline in TB incidence. However, at that current rate, ending the TB epidemic (<10 TB cases/100,000 population) may not be possible soon. As a high TB and TB/HIV burden country, Ethiopia’s TB epidemic is characterized by a high rate of transmission in the general population and hard-to-reach areas and progression of latent TB infection (LTBI) rather than cross-border migration. Studies suggest that a combination of interventions, such as intensive household screening with TB preventive therapy, has the potential to significantly decrease the incidence of TB. The feasibility of reducing the population-level TB incidence by a combination of interventions in Ethiopia is unknown. Based on the World Health Organization’s TB elimination framework and the END TB strategic documents and previously published reviews in TB elimination we conducted a narrative review to summarize and estimated the effect of a combined intervention package (community-based TB screening for active case finding and TB and LTBI prevention and treatment among high-risk groups like household and close contacts). The projected annual decline of TB incidence was above 16%. With this level of impact and nationwide scale-up of the interventions, Ethiopia aligns well with ending the TB epidemic before 2035 and shifting toward TB elimination in the foreseeable future. In the Ethiopia setting, we recommend future studies generating evidence on the impact of the combination intervention package to reduce TB incidence in Ethiopia, which is aiming to shift from control to TB elimination.

[1]  World Health Organizat,et al.  WHO consolidated guidelines on tuberculosis. Module 1: Prevention. Tuberculosis preventive treatment , 2021, Tuberculosis, Lung Diseases, HIV Infection.

[2]  V. Arora,et al.  White paper on challenges and opportunities for TB elimination with focus on COVID & Post-COVID era developed through scientific roundtable resolutions at NATCON 2020 , 2021, Indian Journal of Tuberculosis.

[3]  T. Chorba,et al.  Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  L. Cuevas,et al.  Yield of household contact investigation of patients with pulmonary tuberculosis in southern Ethiopia , 2020, BMC Public Health.

[5]  S. Dorman,et al.  Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis , 2018, The Journal of infectious diseases.

[6]  A. Spanevello,et al.  Tuberculosis elimination: where are we now? , 2018, European Respiratory Review.

[7]  F. Khamis,et al.  Tuberculosis in Gulf Health Council Member States: Opportunities and Challenges Towards TB elimination. , 2018, Oman Medical Journal.

[8]  E. Nardell,et al.  Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment , 2015, The Lancet.

[9]  Francesco Castelli,et al.  Towards tuberculosis elimination: an action framework for low-incidence countries , 2015, European Respiratory Journal.

[10]  C. Sismanidis,et al.  The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  M. Raviglione,et al.  Tuberculosis elimination: dream or reality? The case of Cyprus , 2014, European Respiratory Journal.

[12]  R. Chaisson,et al.  Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control. , 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[13]  A. Spanevello,et al.  Tuberculosis elimination: theory and practice in Europe , 2014, European Respiratory Journal.

[14]  L. Cuevas,et al.  Innovative Community-Based Approaches Doubled Tuberculosis Case Notification and Improve Treatment Outcome in Southern Ethiopia , 2013, PloS one.

[15]  C. Dye,et al.  Prospects for tuberculosis elimination. , 2013, Annual review of public health.

[16]  F. Blasi,et al.  Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe , 2012, European Respiratory Journal.

[17]  D. van Soolingen,et al.  Progress towards tuberculosis elimination: secular trend, immigration and transmission , 2010, European Respiratory Journal.

[18]  D. Falzon,et al.  Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops , 2010, European Respiratory Journal.

[19]  T. Frieden A framework for public health action: the health impact pyramid. , 2010, American journal of public health.

[20]  M Elizabeth Halloran,et al.  Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics , 2009, Proceedings of the National Academy of Sciences.

[21]  B. Lindtjørn,et al.  Health Extension Workers Improve Tuberculosis Case Detection and Treatment Success in Southern Ethiopia: A Community Randomized Trial , 2009, PloS one.

[22]  P. Hopewell,et al.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[23]  C. Dye,et al.  The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. , 2001, The Journal of infectious diseases.

[24]  T. Frieden,et al.  Tuberculosis in New York City--turning the tide. , 1995, The New England journal of medicine.

[25]  Dowdle Wr,et al.  A strategic plan for the elimination of tuberculosis in the United States. , 1989, MMWR. Morbidity and mortality weekly report.

[26]  M. Sugimoto,et al.  Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report. , 1965, The American review of respiratory disease.

[27]  S. Ferebee,et al.  Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. , 2015, The American review of respiratory disease.

[28]  C. Dolea,et al.  World Health Organization , 1949, International Organization.